![]() | Only 14 pages are availabe for public view |
Abstract ral vitamin K antagonists are highly effective in the prevention and treatment of thromboembolic disease. Optimal use of these agents in clinical practice is challenged by their narrow therapeutic window. We used time in therapeutic range (TTR) to estimate quality of anticoagulant control Aim To evaluate time in therapeutic range in patients with non valvular AF and on oral vitamin K antagonist treatment in Delta region. |